In vivonear-infrared fluorescence targeting of T cells: comparison of nanobodies and conventional monoclonal antibodies-Reference-Cited by-同舟云学术

In vivonear-infrared fluorescence targeting of T cells: comparison of nanobodies and conventional monoclonal antibodies

Published:2014-02-12 Issue:2 Volume:9 Page:135-142
ISSN:1555-4309
Container-title:Contrast Media & Molecular Imaging
language:en
Short-container-title:Contrast Media Mol. Imaging

Author:

Bannas Peter¹,Well Lennart¹²,Lenz Alexander¹²,Rissiek Björn²,Haag Friedrich²,Schmid Joanna¹²,Hochgräfe Katja³,Trepel Martin⁴,Adam Gerhard¹,Ittrich Harald¹,Koch-Nolte Friedrich²

Affiliation:

1. Department of Diagnostic and Interventional Radiology; University Medical Center; Hamburg-Eppendorf Germany

2. Institute of Immunology; University Medical Center; Hamburg-Eppendorf Germany

3. German Center for Neurodegenerative Diseases (DZNE); Bonn Germany

4. Department of Oncology and Hematology; University Medical Center; Hamburg-Eppendorf Germany

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Reference32 articles.

1. Molecular theranostics: a primer for the imaging professional;Lee;Am J Roentgenol,2011

2. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice;Lisy;Radiology,2008

3. New technologies for human cancer imaging;Frangioni;J Clin Oncol,2008

4. Design considerations for tumour-targeted nanoparticles;Choi;Nat Nanotechnol,2010

5. Renal clearance of quantum dots;Choi;Nat Biotechnol,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative strategies to study epigenetic regulation and advance precision medicine;Comprehensive Precision Medicine;2024

2. NANOBODY® Molecule, a Giga Medical Tool in Nanodimensions;International Journal of Molecular Sciences;2023-08-25

3. Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants;Expert Opinion on Pharmacotherapy;2023-05-16

4. Potential of Theranostics in Visualisation of the Tumour Microenvironment and Elimination of Its Immunosuppressive Components;The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2022-11-03

5. Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors;Frontiers in Immunology;2022-11-02